AimingMed is a Singapore biotech company specializing in AI-powered organoid technologies, including standardized culture systems, automation, and data analytics. Serving global research, healthcare, and biopharma organizations, it delivers solutions that improve organoid workflow consistency, efficiency, and scalability, advancing precision medicine, drug discovery, and regenerative medicine.